Evidence map›Paper›PMID 34933881›Full record

ArticleCMAJ open

Infection control measures to prevent outbreaks of COVID-19 in Quebec hemodialysis units: a cross-sectional survey.

William Beaubien-Souligny, Annie-Claire Nadeau-Fredette, Marie-Noel Nguyen, Norka Rios, Marie-Line Caron, Alexander Tom, Rita S Suri Md, Quebec Renal Network COVID-19 Study Investigators

Abstract read
In one paragraph

Article in CMAJ open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

William Beaubien-SoulignyDivision of Nephrology (Beaubien-Souligny, Nguyen), Centre hospitalier de l'Université de Montréal; Centre de recherche du Centre hospitalier de l'Université de Montréal (Beaubien-Souligny, Caron, Suri); Division of Nephrology (Nadeau-Fredette), Hôpital Maisonneuve-Rosemont; Research Centre of the Hôpital Maisonneuve-Rosemont (Nadeau-Fredette); Research Institute of the McGill University Health Centre (Rios, Tom, Suri); Division of Nephrology (Suri), Department of Medicine, McGill University, Montréal, Que. rita.suri@mcgill.ca William.beaubien-souligny@umontreal.ca.
Annie-Claire Nadeau-FredetteDivision of Nephrology (Beaubien-Souligny, Nguyen), Centre hospitalier de l'Université de Montréal; Centre de recherche du Centre hospitalier de l'Université de Montréal (Beaubien-Souligny, Caron, Suri); Division of Nephrology (Nadeau-Fredette), Hôpital Maisonneuve-Rosemont; Research Centre of the Hôpital Maisonneuve-Rosemont (Nadeau-Fredette); Research Institute of the McGill University Health Centre (Rios, Tom, Suri); Division of Nephrology (Suri), Department of Medicine, McGill University, Montréal, Que.
Marie-Noel NguyenDivision of Nephrology (Beaubien-Souligny, Nguyen), Centre hospitalier de l'Université de Montréal; Centre de recherche du Centre hospitalier de l'Université de Montréal (Beaubien-Souligny, Caron, Suri); Division of Nephrology (Nadeau-Fredette), Hôpital Maisonneuve-Rosemont; Research Centre of the Hôpital Maisonneuve-Rosemont (Nadeau-Fredette); Research Institute of the McGill University Health Centre (Rios, Tom, Suri); Division of Nephrology (Suri), Department of Medicine, McGill University, Montréal, Que.
Norka RiosDivision of Nephrology (Beaubien-Souligny, Nguyen), Centre hospitalier de l'Université de Montréal; Centre de recherche du Centre hospitalier de l'Université de Montréal (Beaubien-Souligny, Caron, Suri); Division of Nephrology (Nadeau-Fredette), Hôpital Maisonneuve-Rosemont; Research Centre of the Hôpital Maisonneuve-Rosemont (Nadeau-Fredette); Research Institute of the McGill University Health Centre (Rios, Tom, Suri); Division of Nephrology (Suri), Department of Medicine, McGill University, Montréal, Que.
Marie-Line CaronDivision of Nephrology (Beaubien-Souligny, Nguyen), Centre hospitalier de l'Université de Montréal; Centre de recherche du Centre hospitalier de l'Université de Montréal (Beaubien-Souligny, Caron, Suri); Division of Nephrology (Nadeau-Fredette), Hôpital Maisonneuve-Rosemont; Research Centre of the Hôpital Maisonneuve-Rosemont (Nadeau-Fredette); Research Institute of the McGill University Health Centre (Rios, Tom, Suri); Division of Nephrology (Suri), Department of Medicine, McGill University, Montréal, Que.
Alexander TomDivision of Nephrology (Beaubien-Souligny, Nguyen), Centre hospitalier de l'Université de Montréal; Centre de recherche du Centre hospitalier de l'Université de Montréal (Beaubien-Souligny, Caron, Suri); Division of Nephrology (Nadeau-Fredette), Hôpital Maisonneuve-Rosemont; Research Centre of the Hôpital Maisonneuve-Rosemont (Nadeau-Fredette); Research Institute of the McGill University Health Centre (Rios, Tom, Suri); Division of Nephrology (Suri), Department of Medicine, McGill University, Montréal, Que.
Rita S Suri MdDivision of Nephrology (Beaubien-Souligny, Nguyen), Centre hospitalier de l'Université de Montréal; Centre de recherche du Centre hospitalier de l'Université de Montréal (Beaubien-Souligny, Caron, Suri); Division of Nephrology (Nadeau-Fredette), Hôpital Maisonneuve-Rosemont; Research Centre of the Hôpital Maisonneuve-Rosemont (Nadeau-Fredette); Research Institute of the McGill University Health Centre (Rios, Tom, Suri); Division of Nephrology (Suri), Department of Medicine, McGill University, Montréal, Que. rita.suri@mcgill.ca William.beaubien-souligny@umontreal.ca.
Quebec Renal Network COVID-19 Study Investigators

Funding

CIHR 447760
6 · The paper itself

Abstract

backgroundLimited space and resources are potential obstacles to infection prevention and control (IPAC) measures in in-centre hemodialysis units. We aimed to assess IPAC measures implemented in Quebec's hemodialysis units during the spring of 2020, describe the characteristics of these units and document the cumulative infection rates during the first year of the COVID-19 pandemic.

methodsFor this cross-sectional survey, we invited leaders from 54 hemodialysis units in Quebec to report information on the physical characteristics of the unit and their perceptions of crowdedness, which IPAC measures were implemented from Mar. 1 to June 30, 2020, and adherence to and feasibility of appropriate IPAC measures. Participating units were contacted again in March 2021 to collect information on the number of COVID-19 cases in order to derive the cumulative infection rate of each unit.

resultsData were obtained from 38 of the 54 units contacted (70% response rate), which provided care to 4485 patients at the time of survey completion. Fourteen units (37%) had implemented appropriate IPAC measures by 3 weeks after Mar. 1, and all 38 units had implemented them by 6 weeks after. One-third of units were perceived as crowded. General measures, masks and screening questionnaires were used in more than 80% of units, and various distancing measures in 55%-71%; reduction in dialysis frequency was rare. Data on cumulative infection rates were obtained from 27 units providing care to 4227 patients. The cumulative infection rate varied from 0% to 50% (median 11.3%, interquartile range 5.2%-20.2%) and was higher than the reported cumulative infection rate in the corresponding region in 23 (85%) of the 27 units.

interpretationRates of COVID-19 infection among hemodialysis recipients in Quebec were elevated compared to the general population during the first year of the pandemic, and although hemodialysis units throughout the province implemented appropriate IPAC measures rapidly in the spring of 2020, many units were crowded and could not maintain physical distancing. Future hemodialysis units should be designed to minimize airborne and droplet transmission of infection.

Indexed as

Infection ControlRenal DialysisCOVID-19Cross InfectionCross-Sectional StudiesDisease OutbreaksHumansQuebecSurveys and Questionnaires

Identifiers

PMID34933881
PMCPMC8695531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.